Cargando…
Long-Term Valproate Treatment Increases Brain Neuropeptide Y Expression and Decreases Seizure Expression in a Genetic Rat Model of Absence Epilepsy
The mechanisms by which valproate, one of the most widely prescribed anti-epileptic drugs, suppresses seizures have not been fully elucidated but may involve up-regulation of neuropeptide Y (NPY). We investigated the effects of valproate treatment in Genetic Absence Epilepsy Rats from Strasbourg (GA...
Autores principales: | Elms, Johanna, Powell, Kim L., van Raay, Leena, Dedeurwaerdere, Stefanie, O’Brien, Terence J., Morris, Margaret J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767750/ https://www.ncbi.nlm.nih.gov/pubmed/24039965 http://dx.doi.org/10.1371/journal.pone.0073505 |
Ejemplares similares
-
Anti-Epileptic Drug Combination Efficacy in an In Vitro Seizure Model – Phenytoin and Valproate, Lamotrigine and Valproate
por: Taing, Kim Det, et al.
Publicado: (2017) -
An Integrated Multi-Omic Network Analysis Identifies Seizure-Associated Dysregulated Pathways in the GAERS Model of Absence Epilepsy
por: Harutyunyan, Anna, et al.
Publicado: (2022) -
Identification of mRNA expression biomarkers associated with epilepsy and response to valproate with co-expression analysis
por: Min, Jun, et al.
Publicado: (2022) -
Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability
por: Feleke, Rahel, et al.
Publicado: (2022) -
Neurochemical and Behavioral Features in Genetic Absence Epilepsy and in Acutely Induced Absence Seizures
por: Bazyan, A. S., et al.
Publicado: (2013)